Repaglinide--prandial glucose regulator: a new class of oral antidiabetic drugs.

Repaglinide--prandial glucose regulator: a new class of oral antidiabetic drugs.

Item
http://www.wikidata.org/entity/Q34756158
Repaglinide: a new short-acting insulinotropic agent for the treatment of type 2 diabetes.Effects of current therapeutic interventions on insulin resistance.Repaglinide: prandial glucose regulation in clinical practice.Physiology of glucose homeostasis.Pharmacological interventions in type 2 diabetes: the role of nurses.Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications.Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes.Considerations on blood glucose management in Type 2 diabetes mellitus.Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update.Comparison between repaglinide and glipizide in Type 2 diabetes mellitus: a 1-year multicentre study.Comparison of repaglinide vs. gliclazide in combination with bedtime NPH insulin in patients with Type 2 diabetes inadequately controlled with oral hypoglycaemic agents.The effects of diet, sulfonylurea, and Repaglinide therapy on clinical and metabolic parameters in type 2 diabetic patients during Ramadan.Improvement of insulin sensitivity and beta-cell function by nateglinide and repaglinide in type 2 diabetic patients - a randomized controlled double-blind and double-dummy multicentre clinical trial.Enhancement of solubility and antidiabetic effects of Repaglinide using spray drying technique in STZ-induced diabetic rats.A sensitive chemiluminescent immunoassay for point-of-care testing of repaglinide in natural dietary supplements and serum.Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial.
P2860

Repaglinide--prandial glucose regulator: a new class of oral antidiabetic drugs.

Item
http://www.wikidata.org/entity/Q34756158
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Repaglinide--prandial glucose regulator: a new class of oral antidiabetic drugs.
@ast
Repaglinide--prandial glucose regulator: a new class of oral antidiabetic drugs.
@en
Repaglinide--prandial glucose regulator: a new class of oral antidiabetic drugs.
@nl
type
label
Repaglinide--prandial glucose regulator: a new class of oral antidiabetic drugs.
@ast
Repaglinide--prandial glucose regulator: a new class of oral antidiabetic drugs.
@en
Repaglinide--prandial glucose regulator: a new class of oral antidiabetic drugs.
@nl
prefLabel
Repaglinide--prandial glucose regulator: a new class of oral antidiabetic drugs.
@ast
Repaglinide--prandial glucose regulator: a new class of oral antidiabetic drugs.
@en
Repaglinide--prandial glucose regulator: a new class of oral antidiabetic drugs.
@nl
P1433
P1476
P2093
P304
P31
P356
P478
P577
P698
P356
P1433
P1476
Repaglinide--prandial glucose regulator: a new class of oral antidiabetic drugs.
@en
P2093
P304
P31
P356
10.1002/(SICI)1096-9136(1998120)15:4+<S28::AID-DIA748>3.3.CO;2-K
P478
P577
P698